top of page
  • Exchanges

Ferring Pharmaceuticals to Issue Biomarker Research Grants

© Hatzel & Buehler
© Hatzel & Buehler

Applications for Ferring Pharmaceuticals’ Innovation Grants Program are open until June 11th.  Non-renewable awards of $50,000 to $100,000 are available to support research on biomarkers relevant to the company’s core therapeutic areas, including reproductive health. The program’s discovery grants will support further research on targets with existing in vitro data and its exploratory grants will  support feasibility studies. The program will also fund Postdoctoral and Graduate Student Fellowships.

For more information, or to apply, click here.

bottom of page